Xiang YQ[Author] - Search Results

Year	Number of Results
2000	1
2004	4
2005	2
2006	4
2007	1
2008	8
2009	7
2010	5
2011	4
2012	8
2013	9
2014	5
2015	9
2016	19
2017	15
2018	9
2019	7
2020	10
2021	3

1

Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies.

Zheng W, Cai DB, Xiang YQ, Zheng W, Jiang WL, Sim K, Ungvari GS, Huang X, Huang XX, Ning YP, Xiang YT. Zheng W, et al. Among authors: xiang yq. J Affect Disord. 2020 Mar 15;265:63-70. doi: 10.1016/j.jad.2020.01.002. Epub 2020 Jan 3. J Affect Disord. 2020. PMID: 31957693

2

Epstein-Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3.

Jiang C, Li L, Xiang YQ, Lung ML, Zeng T, Lu J, Tsao SW, Zeng MS, Yun JP, Kwong DLW, Guan XY. Jiang C, et al. Among authors: xiang yq. Cancer Res. 2020 May 15;80(10):1957-1969. doi: 10.1158/0008-5472.CAN-19-0334. Epub 2020 Feb 14. Cancer Res. 2020. PMID: 32060148

3

Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis.

Pan JX, Tan YJ, Wang FF, Hou NN, Xiang YQ, Zhang JY, Liu Y, Qu F, Meng Q, Xu J, Sheng JZ, Huang HF. Pan JX, et al. Among authors: xiang yq. Clin Epigenetics. 2018 Jan 12;10:6. doi: 10.1186/s13148-018-0442-y. eCollection 2018. Clin Epigenetics. 2018. PMID: 29344314 Free PMC article.

4

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY. Yang Q, et al. Among authors: xiang yq. Eur J Cancer. 2019 Sep;119:87-96. doi: 10.1016/j.ejca.2019.07.007. Epub 2019 Aug 16. Eur J Cancer. 2019. PMID: 31425966 Clinical Trial.

5

Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.

Zheng W, Xiang YT, Yang XH, Xiang YQ, de Leon J. Zheng W, et al. Among authors: xiang yq. J Clin Psychiatry. 2017 May;78(5):e498-e505. doi: 10.4088/JCP.16r10782. J Clin Psychiatry. 2017. PMID: 28355041

6

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Tang LQ, et al. Among authors: xiang yq. Lancet Oncol. 2018 Apr;19(4):461-473. doi: 10.1016/S1470-2045(18)30104-9. Epub 2018 Feb 28. Lancet Oncol. 2018. PMID: 29501366 Clinical Trial.

7

Tai chi for mild cognitive impairment: a systematic review.

Zheng W, Xiang YQ, Ungvari GS, Chiu HFK, Ning YP, Yu X, Forester BP, Xiang YT. Zheng W, et al. Among authors: xiang yq. Psychogeriatrics. 2017 Nov;17(6):514-516. doi: 10.1111/psyg.12269. Epub 2017 Jul 13. Psychogeriatrics. 2017. PMID: 28703397 Review. No abstract available.

8

Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease.

Xiang YQ, Xu Q, Sun QY, Wang ZQ, Tian Y, Fang LJ, Yang Y, Tan JQ, Yan XX, Tang BS, Guo JF. Xiang YQ, et al. Front Neurol. 2019 Feb 19;10:121. doi: 10.3389/fneur.2019.00121. eCollection 2019. Front Neurol. 2019. PMID: 30837940 Free PMC article.

9

Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma.

Mai J, Zhong ZY, Guo GF, Chen XX, Xiang YQ, Li X, Zhang HL, Chen YH, Xu XL, Wu RY, Yu Y, Li ZL, Peng XD, Huang Y, Zhou LH, Feng GK, Guo X, Deng R, Zhu XF. Mai J, et al. Among authors: xiang yq. Theranostics. 2019 May 26;9(12):3541-3554. doi: 10.7150/thno.32908. eCollection 2019. Theranostics. 2019. PMID: 31281496 Free PMC article.

10

Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9.

Hu TT, Yang JW, Yan Y, Chen YY, Xue HB, Xiang YQ, Ye LC. Hu TT, et al. Among authors: xiang yq. Biosci Rep. 2020 Oct 30;40(10):BSR20201125. doi: 10.1042/BSR20201125. Biosci Rep. 2020. PMID: 33048115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results